Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 483-310-2 | CAS number: 101023-55-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Bacterial reverse mutation assay/Ames test: negative (OECD 471; GLP)
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 2004-12-08 to 2004-12-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Read-across from imidazole hydrobromide to imidazole hydroiodide is justified since both substances only differ in the respective counterion iodide or bromide. Both anions iodide and bromide are quite similar concerning toxicological behaviour and thus do not influence the toxicological results received.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997-07-21
- Deviations:
- yes
- Remarks:
- growth phase not mentioned; not clear if amino acid requirement was tested; number of cells per culture were not stated
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 2002-01-14
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature, light protected - Target gene:
- TA1537: his C 3076
TA98: his D 3052
TA1535 & TA100: his G 46
WP2 uvrA: trp- - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix (containing 15 % S9): 8 mM MgCl2, 33 mM KCl, 5 mM glucose-6-phosphate, and 5 mM NADP in 100 mM sodium-ortho-phosphate-buffer, pH 7.4
- Test concentrations with justification for top dose:
- Pre-experiment/Experiment 1: 3, 10, 33, 100, 333, 1000, 2500, and 5000 µg/plate (with and without metabolic activation)
Experiment 2: 33, 100, 333, 1000, 2500, and 5000 µg/plate (with and without metabolic activation)
In the pre-experiment no toxic effects were observed and 5000 μg/plate were chosen as maximal concentration. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionised water
- Justification for choice of solvent/vehicle: solvent was chosen because of its solubility properties (Maron et al., 1981)*.
*Reference:
Maron, D.M., J. Katzenellenbogen and B.N. Ames, (1981) Compantibility of organic solvents with the Salmonella/Microsome Test. Mutation Res. 88, 343 - 350. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- deionised water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 2-aminoantracene (2-AA) & 4-nitro-o-phenylene-diamine (4-NOPD)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation; pre-experiment/experiment 1) and preincubation (experiment 2)
PRE-EXPERIMENT/EXPERIMENT 1:
To evaluate the toxicity of the test item a pre-experiment was performed with all strains. Eight concentrations were tested for toxicity and mutation induction with three plates each.
The following materials were mixed in a test tube and poured onto the selective agar plates:
- 100 μL test solution at each dose level, negative control or positive control,
- 500 μL S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test without metabolic activation),
- 100 μL bacteria suspension,
- 2000 μL overlay agar
After solidification the plates were incubated upside down for at least 48 hours at 37° C in the dark.
Toxicity of the test item results in a reduction in the number of spontaneous revertants or a clearing of the bacterial background lawn.
The pre-experiment is reported as main experiment 1, if the following criteria are met: evaluable plates (>0 colonies) at five concentrations or more in all strains used.
The pre-experiment is reported as experiment 1 since no toxic effects were observed and 5000 μg/plate were chosen as maximal concentration.
EXPERIMENT 2
In the pre-incubation assay 100 μL test solution, 500 μL S9 mix/S9 mix substitution buffer and 100 μL bacterial suspension were mixed in a test tube and shaken at 37° C for 60 minutes. After pre-incubation 2.0 mL overlay agar (45° C) was added to each tube. The mixture was poured on selective agar plates.
After solidification the plates were incubated upside down for at least 48 hours at 37° C in the dark.
NUMBER OF REPLICATIONS: triplicates/strain/dose level (incl. controls)
EVALUATION:
The colonies were counted using the Petri Viewer Mk2 (Perceptive Instruments Ltd, Suffolk CB 7BN, UK) with the software program Ames Study Manager. - Rationale for test conditions:
- In the pre-experiment no toxic effects were observed and 5000 μg/plate were chosen as maximal concentration.
No precipitation of the test item occurred up to the highest investigated dose. - Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA98, TA100, and WP2 uvrA) or thrice (strains TA1535 and TA1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- No statistical evaluation of the data is required.
- Key result
- Species / strain:
- other: Salmonella typhimurium TA98, TA100, TA1535, and TA1537 as well as E. coli WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- precipitation: no precipitation of the test item occurred up to the highest investigated dose.
PRE-EXPERIMENT/EXPERIMENT 1 & EXPERMENT 2
- plates incubated with the test item showed normal background growth up to 5000 μg/plate with and without S9 mix in both experiments.
- no toxic effects, evident as a reduction in the number of revertants, occurred in the test groups with and without metabolic activation.
- no substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with the test item at any dose level, neither in the presence nor absence of metabolic activation. There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
- positive controls showed a distinct increase of induced revertant colonies.
- number of colonies exceeded the laboratory's historical control range in the negative control of strain WP2 uvrA with and without metabolic activation in experiment 1, and in the solvent control of strain TA1535 without metabolic activation in experiment 2. In experiment 2, with metabolic activation, the number of colonies did not quite reach the lower limit of the laboratory's historical control data in strain TA100 (negative control). Since these deviations are rather small, these effects are judged to be based on biologically irrelevant fluctuations in the number of colonies and have no impact on the outcome of the study.
- historical range of positive controls was exceeded with metabolic activation in strains TA1535, TA1537, and TA98 in experiment 1 and in strain TA 100 in experiment 2. This effect indicates the sensitivity of the strains rather than compromising the assay.
Please also refer to the field "Attached background material" below.
HISTORICAL CONTROL DATA
- Positive historical control data / Negative (solvent/vehicle) historical control data: please refer to Table 1 in the field "Any other information on results incl. tables" below. - Conclusions:
- The substance tested non-mutagenic under the conditions of the study.
According to Regulation (EC) No 1272/2008 and subsequent adaptations, the substance should not be considered to have a mutagenic potential.
Reference
Table 1: Historical control data
Strain |
|
without S9 mix |
with S9 mix |
||||||
|
Mean |
SD |
Min |
Max |
Mean |
SD |
Min |
Max |
|
TA1535 |
Solvent control |
20 |
6 |
9 |
30 |
18 |
10 |
7 |
39 |
Negative contol |
18 |
5 |
10 |
29 |
18 |
10 |
9 |
38 |
|
Positive control |
3042 |
756 |
1003 |
3618 |
357 |
111 |
172 |
476 |
|
TA1537 |
Solvent control |
11 |
7 |
4 |
29 |
18 |
9 |
6 |
31 |
Negative contol |
12 |
6 |
5 |
29 |
18 |
6 |
8 |
29 |
|
Positive control |
97 |
21 |
52 |
191 |
141 |
47 |
94 |
380 |
|
TA98 |
Solvent control |
24 |
9 |
14 |
58 |
37 |
13 |
21 |
57 |
Negative contol |
26 |
10 |
15 |
52 |
43 |
15 |
17 |
64 |
|
Positive control |
379 |
98 |
137 |
976 |
1239 |
510 |
229 |
2566 |
|
TA100 |
Solvent control |
121 |
29 |
91 |
198 |
149 |
36 |
109 |
281 |
Negative contol |
141 |
23 |
101 |
189 |
147 |
43 |
103 |
254 |
|
Positive control |
2089 |
408 |
1262 |
2872 |
921 |
346 |
546 |
2589 |
|
WP2 uvrA |
Solvent control |
50 |
16 |
34 |
65 |
53 |
17 |
34 |
65 |
Negative contol |
51 |
10 |
38 |
63 |
50 |
13 |
35 |
60 |
|
Positive control |
536 |
294 |
320 |
1976 |
346 |
38 |
221 |
415 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Genetic toxicity in vitro
The substance was not observed to be mutagenic in a reliable bacterial reverse mutation assay (OECD 471).
Justification for classification or non-classification
Genetic toxicity in vitro
The substance should not be considered to have a mutagenic potential based on a bacterial reverse mutation assay (OECD 471). The substance does not require classification according to Regulation (EC) No 1272/2008 and subsequent adaptations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
